Paclitaxel: a new antineoplastic agent.
Hitt
C
C
Hartford Hospital.
D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D009369:Neoplasms / Q000097:blood / Q000188:drug therapy*; D017239:Paclitaxel / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*
D017239:Paclitaxel